Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-015399

Options or other derivatives

  • EVP, Head of North America acquired 54,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lee Jennifer Kayden EVP, Head of North America 2026-02-11 Grant or award · Restricted Stock Units +21,650 21,650 D
Lee Jennifer Kayden EVP, Head of North America 2026-02-11 Grant or award · Stock Options (Right to Buy) +32,500 32,500 D
Loading xslF345X05/tm266366-4_4seq1.xml…